Cell growth and signaling, as well as cholesterol production, are significantly altered in lab-grown astrocytes — the star-shaped brain cells…
Articles by Lindsey Shapiro, PhD
KGK Science is requesting permission from Health Canada to conduct a Phase 2a clinical trial evaluating a microdose of…
A month of treatment with retinoic acid — a naturally occurring byproduct of vitamin A — was able to restore…
People with fragile X syndrome have significantly lower levels of fatty acids — a type of fatty molecule essential…
A gene therapy using a modified form of an enzyme called diacylglycerol kinase kappa (DGKk) led to the long-term rescue…
The University College of London (UCL) has licensed VSN16R, an investigational oral treatment for fragile X syndrome, to U.S.-based…
The European Commission has granted orphan drug designation to Zygel, Zynerba Pharmaceuticals’ cannabidiol (CBD) transdermal gel candidate to treat…